bearish
Genscript Biotech IPO - Financial Track Record Doesn't Inspire Much Confidence
373 Views18 Dec 2015 15:45
Genscript Biotech (GS) plans to raise US$70-90m through its IPO. This is a follow up note to Kemp Dolliver, CFA 's insight An Intriguing Small Cap...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Global #1 Gene Synthesis Provider, But The Stock Is Fairly Valued21 Sep 2021
- Genscript Biotech Placement - Raising Money to Build Up CAR-T R&D and Production Facilities04 Jun 2018
- Genscript Biotech IPO - Financial Track Record Doesn't Inspire Much Confidence18 Dec 2015
- An Intriguing Small Cap with Price Risk18 Dec 2015
x